CLINICAL_TRIALS
trial_result
· 2023-12-12
Clinical Trial Update: Feasibility and Preliminary Effects of MR-005 in Persons With Parkinson Disease [NA]
Summary
Feasibility and preliminary effects study of MR-005 in individuals with Parkinson disease has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MedRhythms, Inc. | Conditions: Parkinson Disease | NA | Status: COMPLETED | Results posted: 2023-12-12